Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,555,700 shares, a decline of 7.7% from the March 15th total of 1,684,700 shares. Based on an average daily trading volume, of 1,083,800 shares, the days-to-cover ratio is presently 1.4 days.
Elite Pharmaceuticals Stock Up 3.7 %
ELTP opened at $0.14 on Wednesday. The company has a market cap of $149.56 million, a P/E ratio of 14.01 and a beta of -0.16. Elite Pharmaceuticals has a 12 month low of $0.03 and a 12 month high of $0.21. The business’s 50-day moving average price is $0.16 and its 200-day moving average price is $0.15. The company has a current ratio of 1.94, a quick ratio of 1.19 and a debt-to-equity ratio of 0.08.
Elite Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Elite Pharmaceuticals
- How to Buy Cheap Stocks Step by Step
- Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
- How to Invest in Small Cap StocksÂ
- Checking in with 5 Bitcoin Stocks Ahead of Bitcoin’s Halving
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Commercial Banks Could Be Back in Play, Led by Bank of America
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.